EPHA2 and chondrosarcoma: We believe that the data presented in this article warrant further studies in the field of osteosarcoma, Ewing’s sarcoma and, especially, chondrosarcoma, in which EphA2 pathway activation has not been previously reported and might represent a therapeutic opportunity for this disease.